EB1-3 Chain of IL-35 Along With TGF-β Synergistically Regulate Anti-leishmanial Immunity.
Leishmania
immune response
immune suppression
interleukin-35
regulatory T cells
transforming growth factor beta
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2019
2019
Historique:
received:
26
07
2018
accepted:
08
03
2019
entrez:
30
4
2019
pubmed:
30
4
2019
medline:
30
4
2019
Statut:
epublish
Résumé
Immunosuppression is a characteristic feature of chronic leishmaniasis. The dynamicity and the functional cross talks of host immune responses during
Identifiants
pubmed: 31031744
doi: 10.3389/fimmu.2019.00616
pmc: PMC6474326
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
616Commentaires et corrections
Type : ErratumIn
Références
Clin Diagn Lab Immunol. 2000 Mar;7(2):233-40
pubmed: 10702498
Infect Immun. 2002 Nov;70(11):6284-93
pubmed: 12379707
Eur J Immunol. 2002 Dec;32(12):3556-65
pubmed: 12516540
Parasitol Int. 2005 Jun;54(2):139-46
pubmed: 15866476
Infect Immun. 2005 Jul;73(7):3903-11
pubmed: 15972476
Trends Immunol. 2007 Sep;28(9):378-84
pubmed: 17689290
Eur J Immunol. 2007 Nov;37(11):3021-9
pubmed: 17874423
J Immunol. 2008 Mar 15;180(6):4090-7
pubmed: 18322219
PLoS Pathog. 2008 Feb 29;4(2):e1000028
pubmed: 18463695
J Immunol. 2008 Jul 15;181(2):1386-98
pubmed: 18606693
Infect Immun. 2009 Apr;77(4):1514-23
pubmed: 19168736
Indian J Exp Biol. 2009 Jun;47(6):489-97
pubmed: 19634715
J Lipid Res. 2010 May;51(5):1208-17
pubmed: 20007839
BMC Microbiol. 2010 Jun 24;10:181
pubmed: 20576102
Nat Immunol. 2010 Dec;11(12):1093-101
pubmed: 20953201
PLoS Pathog. 2012 Jan;8(1):e1002417
pubmed: 22275864
Nat Immunol. 2012 Jul 19;13(8):722-8
pubmed: 22814351
PLoS Pathog. 2012;8(7):e1002827
pubmed: 22911108
Semin Immunopathol. 2012 Nov;34(6):735-51
pubmed: 23053396
J Immunol. 2013 Mar 1;190(5):2415-23
pubmed: 23345334
J Clin Invest. 2013 Mar;123(3):939-44
pubmed: 23454755
Infect Immun. 2013 Jul;81(7):2318-26
pubmed: 23589575
PLoS Negl Trop Dis. 2014 Feb 13;8(2):e2567
pubmed: 24551250
Nat Immunol. 2014 Jun;15(6):580-587
pubmed: 24728351
PLoS Pathog. 2014 Jun 26;10(6):e1004165
pubmed: 24967908
J Dig Dis. 2015 Jan;16(1):1-6
pubmed: 25476593
BMC Infect Dis. 2015 Apr 17;15:188
pubmed: 25884796
Pathog Dis. 2015 Nov;73(8):ftv063
pubmed: 26297915
J Antimicrob Chemother. 2015 Dec;70(12):3283-90
pubmed: 26346991
Eur J Immunol. 2016 Mar;46(3):752-61
pubmed: 26638865
PLoS Pathog. 2016 Jan 14;12(1):e1005398
pubmed: 26765224
PLoS Negl Trop Dis. 2016 Feb 01;10(2):e0004422
pubmed: 26829554
PLoS Negl Trop Dis. 2016 Feb 12;10(2):e0004415
pubmed: 26872334
Immunity. 2016 Feb 16;44(2):316-29
pubmed: 26872697
Parasit Vectors. 2016 Mar 01;9:118
pubmed: 26932389
J Biol Regul Homeost Agents. 2016 Jul-Sep;30(3):675-682
pubmed: 27655484
PLoS One. 2016 Sep 22;11(9):e0163604
pubmed: 27658046
PLoS Pathog. 2016 Oct 7;12(10):e1005924
pubmed: 27716848
PLoS Negl Trop Dis. 2016 Oct 14;10(10):e0005035
pubmed: 27741241
J Immunol. 2016 Nov 15;197(10):3762-3770
pubmed: 27815439
PLoS One. 2017 Feb 7;12(2):e0171306
pubmed: 28170432
Braz J Infect Dis. 2017 Sep - Oct;21(5):545-549
pubmed: 28606413
Front Immunol. 2017 Aug 10;8:893
pubmed: 28848541
Nat Commun. 2017 Sep 28;8(1):719
pubmed: 28959012
Front Immunol. 2018 Jan 30;9:18
pubmed: 29441060
Sci Rep. 2018 Feb 22;8(1):3500
pubmed: 29472618
Int J Cancer. 2018 Nov 1;143(9):2105-2115
pubmed: 29574719
Autoimmun Rev. 2018 Jul;17(7):665-673
pubmed: 29729445
Infect Immun. 1997 Jun;65(6):2371-7
pubmed: 9169776
Infect Immun. 1998 Mar;66(3):1233-6
pubmed: 9488418